Financhill
Back

Xperi, Inc. Vs. Apogee Therapeutics, Inc. Industry Stock Comparison

Sell
23

XPER
Xperi, Inc.

Last Price:
$5.72
Seasonality Move:
-4.69%
Sell
44

APGE
Apogee Therapeutics, Inc.

Last Price:
$84.40
Seasonality Move:
-11.77%
Sell
23
Xperi, Inc. (XPER) is a Sell

Is Xperi, Inc. a Buy, Sell or Hold?

  • The current Xperi, Inc. [XPER] share price is $5.72. The Score for XPER is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • XPER is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Apogee Therapeutics, Inc. (APGE) is a Sell

Is Apogee Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Apogee Therapeutics, Inc. [APGE] share price is $84.34. The Score for APGE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • APGE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XPER Stock Price Chart

What is Xperi, Inc.'s stock price today?

  • The Xperi, Inc. share price today is $5.72
    The current trend is relatively stagnant and XPER is experiencing buying pressure, which is a positive indicator for future bullish movement.

APGE Stock Price Chart

What is Apogee Therapeutics, Inc.'s stock price today?

  • The Apogee Therapeutics, Inc. share price today is $84.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APGE is experiencing buying pressure, which is a positive indicator for future bullish movement.

XPER Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 49.91 Sell
Chaikin Money Flow: 120906 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.6 - 6.1) Sell
Bollinger Bands (100): (5.55 - 6.17) Sell

APGE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.18 Buy
Relative Strength Index (14 RSI): 64.96 Buy
Chaikin Money Flow: 432550 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (69.1 - 79.44) Buy
Bollinger Bands (100): (66.23 - 78.47) Buy

XPER Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.6 Buy
20-day SMA: 5.75 Sell
50-day SMA: 5.71 Buy
200-day SMA: 6.29 Sell
8-day EMA: 5.65 Buy
20-day EMA: 5.71 Buy
50-day EMA: 5.77 Sell
200-day EMA: 6.36 Sell

APGE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 79.91 Buy
20-day SMA: 75.21 Buy
50-day SMA: 71.36 Buy
200-day SMA: 57.28 Buy
8-day EMA: 80.37 Buy
20-day EMA: 76.41 Buy
50-day EMA: 73.33 Buy
200-day EMA: 61.58 Buy

Xperi, Inc. Earnings Growth & XPER Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.08 per share, an increase this year of $0.26 per share, and an increase next year of $0.23 per share.

Apogee Therapeutics, Inc. Earnings Growth & APGE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.21 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.62 per share.

Xperi, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apogee Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):